Sonnet BioTherapeutics Holdings, Inc.

The current price of SONN is 1.77 USD — it has increased by 4.12% in the past 24 hours.

Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Sonnet BioTherapeutics Holdings, Inc. stocks are traded under the ticker SONN.

Sonnet BioTherapeutics Holdings, Inc. is going to release the next earnings report on May 8, 2024. Keep track of upcoming events with our Earnings Calendar.

SONN stock is 4.41% volatile and has beta coefficient of 3.30. Check out the list of the most volatile stocks — is Sonnet BioTherapeutics Holdings, Inc. there?

One year price forecast for Sonnet BioTherapeutics Holdings, Inc. has a max estimate of 30.00 USD and a min estimate of 2.00 USD.

SONN earnings for the last quarter are −9.48 USD whereas the estimation was −2.63 USD which accounts for −259.83% surprise. Estimated earnings for the next quarter are −0.63 USD. See more details about Sonnet BioTherapeutics Holdings, Inc. earnings.

Sonnet BioTherapeutics Holdings, Inc. revenue for the last quarter amounts to ‪19.00 K‬ USD despite the estimated figure of ‪31.10 K‬ USD. In the next quarter revenue is expected to reach ‪27.50 K‬ USD.

Yes, you can track Sonnet BioTherapeutics Holdings, Inc. financials in yearly and quarterly reports right on TradingView.

SONN net income for the last quarter is ‪−1.17 M‬ USD, while the quarter before that showed ‪−3.68 M‬ USD of net income which accounts for 68.22% change. Track more Sonnet BioTherapeutics Holdings, Inc. financial stats to get the full picture.

Today Sonnet BioTherapeutics Holdings, Inc. has the market capitalization of ‪5.43 M‬, it has increased by 6.82% over the last week.

No, SONN doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.

Like other stocks, SONN shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Sonnet BioTherapeutics Holdings, Inc. stock right from TradingView charts — choose your broker and connect to your account.

SONN reached its all-time high on Jul 27, 2005 with the price of 1201200.00 USD, and its all-time low was 1.08 USD and was reached on Oct 26, 2023.
See other stocks reaching their highest and lowest prices.

As of Apr 19, 2024, the company has 12.00 employees. See our rating of the largest employees — is Sonnet BioTherapeutics Holdings, Inc. on this list?

Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Sonnet BioTherapeutics Holdings, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Sonnet BioTherapeutics Holdings, Inc. stock shows the sell signal. See more of Sonnet BioTherapeutics Holdings, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.

We've gathered analysts' opinions on Sonnet BioTherapeutics Holdings, Inc. future price: according to them, SONN price has a max estimate of 30.00 USD and a min estimate of 2.00 USD. Read a more detailed Sonnet BioTherapeutics Holdings, Inc. forecast: see what analysts think of Sonnet BioTherapeutics Holdings, Inc. and suggest that you do with its stocks.

EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Sonnet BioTherapeutics Holdings, Inc. EBITDA is ‪−14.20 M‬ USD, and current EBITDA margin is ‪−12.47 K‬%. See more stats in Sonnet BioTherapeutics Holdings, Inc. financial statements.